- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT06001918
Nectero EAST System klinisk undersøgelse (stAAAble)
Randomiseret kontrolleret klinisk forsøg (RCT) af Nectero EAST-systemet for små til mellemstore abdominale aortaaneurismer (AAA) StaBiLisering: Evaluering af effektivitet.
The purpose of this randomized clinical trial is to treat patients with small to mid-sized abdominal aortic aneurysms (AAA), maximum diameter of 3.5 cm to 5.0 cm, using a locally delivered, single-dose endovascular treatment. The main question the study aims to answer is to demonstrate efficacy of the product for stabilization of these small to mid-sized AAA.The study will compare the treatment group to the typical standard of care for these patients, surveillance. All subjects will be followed at designated intervals at 30/60 days, 6, 12, 18 and 24 months with continued follow-up annually for up to 5 years.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Fase 2
- Fase 3
Kontakter og lokationer
Studiekontakt
- Navn: Charlene Knape
- Telefonnummer: 866-755-4744
- E-mail: cknape@necteromedical.com
Undersøgelse Kontakt Backup
- Navn: Tracy Roberts
- Telefonnummer: (303)3964603
- E-mail: troberts@necteromedical.com
Studiesteder
-
-
New South Wales
-
Randwick, New South Wales, Australien, 2031
- Rekruttering
- Prince of Wales Private Hospital- POW Vascular Institute
-
Ledende efterforsker:
- Ramon Varcoe
-
Kontakt:
- Jade Goh
- Telefonnummer: 04 87 369 396
- E-mail: pow.vascular.institute@gmail.com
-
-
-
-
Arizona
-
Scottsdale, Arizona, Forenede Stater, 85258
- Rekruttering
- Honor Health Scottsdale Shea Medical Center
-
Ledende efterforsker:
- Hasan Aldailami, MD
-
Kontakt:
- HonorHealth Cardiovascular Research
- Telefonnummer: 480-323-1046
-
-
Colorado
-
Aurora, Colorado, Forenede Stater, 80045
- Aktiv, ikke rekrutterende
- University of Colorado
-
-
District of Columbia
-
Washington D.C., District of Columbia, Forenede Stater, 20010
- Rekruttering
- Medstar Washington Hospital Center
-
Ledende efterforsker:
- Steven Abramowitz, MD
-
Kontakt:
- Kassaye Sesaba, MD
- Telefonnummer: 202-877-7452
- E-mail: Kassaye.T.Sesaba@medstar.net
-
Kontakt:
- Suman Singh, MD
- Telefonnummer: (202) 877-8475
- E-mail: Suman.Singh@Medstar.net
-
-
Florida
-
Delray Beach, Florida, Forenede Stater, 33446
- Rekruttering
- Prime Vascular Institute
-
Ledende efterforsker:
- Joseph Ricotta, MD
-
Kontakt:
- Jordan Sprechman
- Telefonnummer: 561-495-3145
- E-mail: Jordan.Sprechman@tenethealth.com
-
Kontakt:
- Alexia Medick
- E-mail: Alexia.Medick@tenethealth.com
-
-
Georgia
-
Augusta, Georgia, Forenede Stater, 30912
- Rekruttering
- Medical College of Georgia
-
Ledende efterforsker:
- William Jordan, MD
-
Kontakt:
- Natasha Flores
- E-mail: nflores@augusta.edu
-
Kontakt:
- Candelario Laserna
- Telefonnummer: 706-721-2199
- E-mail: calaserna@augusta.edu
-
-
Illinois
-
Chicago, Illinois, Forenede Stater, 60637
- Rekruttering
- University of Chicago
-
Kontakt:
- MacKenton Johnson
- Telefonnummer: 773-795-3639
- E-mail: mackenton@bsd.uchicago.edu
-
Ledende efterforsker:
- Ross Milner, MD
-
Elk Grove, Illinois, Forenede Stater, 60007
- Ikke rekrutterer endnu
- Ascension Alexian Brothers
-
Ledende efterforsker:
- Jack Chamberlin, MD
-
-
Maine
-
Scarborough, Maine, Forenede Stater, 04074
- Rekruttering
- MaineMed Vascular Surgery
-
Ledende efterforsker:
- Kristina Giles, MD
-
Kontakt:
- Kathryn Ackermann
- E-mail: kathryn.ackermann@mainehealth.org
-
-
Massachusetts
-
Boston, Massachusetts, Forenede Stater, 02114
- Rekruttering
- Massachusetts General Hospital
-
Ledende efterforsker:
- Nikolaos Zacharias, MD
-
Kontakt:
- Bonnie Chen
- E-mail: BCHEN13@mgh.harvard.edu
-
Boston, Massachusetts, Forenede Stater, 02215
- Rekruttering
- Beth Israel Deaconess Medical Center
-
Ledende efterforsker:
- Marc Schermerhorn, MD
-
Kontakt:
- Monica Goyal
- Telefonnummer: 617-632-7534
- E-mail: mgoyal@bidmc.harvard.edu
-
Kontakt:
- Fernando Moreno
- E-mail: fmoreno@bidmc.harvard.edu
-
Worcester, Massachusetts, Forenede Stater, 01655
- Rekruttering
- University of Massachusetts
-
Kontakt:
- Shauneen Valliere
- E-mail: shauneen.valliere@umassmed.edu
-
Ledende efterforsker:
- Andres Schanzer, MD
-
-
Michigan
-
Royal Oak, Michigan, Forenede Stater, 48073
- Rekruttering
- Beaumont Health
-
Ledende efterforsker:
- Graham Long, MD
-
Kontakt:
- Lisa Bliss
- E-mail: lisa.bliss@corewellhealth.org
-
-
Missouri
-
St Louis, Missouri, Forenede Stater, 63110
- Rekruttering
- Washington University School of Medicine
-
Ledende efterforsker:
- Luis Sanchez, MD
-
Kontakt:
- Briana K Langrehr, BSN
- E-mail: briana.l@wustl.edu
-
-
Nebraska
-
Omaha, Nebraska, Forenede Stater, 68198
- Rekruttering
- University of Nebraska Medical Center
-
Ledende efterforsker:
- Jonathan Thompson, MD
-
Kontakt:
- Jarod Phillips
- E-mail: jarphillips@unmc.edu
-
-
New Hampshire
-
Lebanon, New Hampshire, Forenede Stater, 03766
- Rekruttering
- Dartmouth Hitchcock Medical Center
-
Ledende efterforsker:
- Rebecca Scully, MD
-
Kontakt:
- Pauline Sirrell
- E-mail: pauline.sirrell@hitchcock.org
-
-
New York
-
Rochester, New York, Forenede Stater, 14642
- Rekruttering
- University of Rochester
-
Kontakt:
- Mary Bourret
- E-mail: Mary_Bourret@URMC.Rochester.edu
-
Ledende efterforsker:
- Doran Mix, MD
-
Stony Brook, New York, Forenede Stater, 11794
- Ikke rekrutterer endnu
- Stony Brook Medicine
-
Ledende efterforsker:
- Rabih Chaer, MD
-
Kontakt:
- Daria Shavarina
- E-mail: Daria.Shavarina@stonybrookmedicine.edu
-
-
North Carolina
-
Durham, North Carolina, Forenede Stater, 27710
- Rekruttering
- Duke University Medical Center
-
Ledende efterforsker:
- Chandler Long, MD
-
Kontakt:
- Ellen Burkett
- Telefonnummer: (919)681-1878
- E-mail: ellen.jones@duke.edu
-
-
Ohio
-
Cincinnati, Ohio, Forenede Stater, 45219
- Rekruttering
- The Christ Hospital
-
Kontakt:
- Jamie Elkins
- E-mail: Jamie.Elkins@thechristhospital.com
-
Ledende efterforsker:
- Geoff Answini, MD
-
Cleveland, Ohio, Forenede Stater, 44106
- Rekruttering
- University Hospitals Cleveland
-
Ledende efterforsker:
- Jae Cho, MD
-
Kontakt:
- Amy Kluge
- E-mail: Amy.Kluge@UHhospitals.org
-
Cleveland, Ohio, Forenede Stater, 44195
- Rekruttering
- Cleveland Clinic
-
Ledende efterforsker:
- Francis Caputo, MD
-
Kontakt:
- Laurie Ann Moennich
- E-mail: MOENNIL@ccf.org
-
Columbus, Ohio, Forenede Stater, 43210
- Rekruttering
- The Ohio State University Wexner Medical Center
-
Kontakt:
- Subh Das
- Telefonnummer: 614-366-6596
- E-mail: subhashish.das@osumc.edu
-
Ledende efterforsker:
- Kristine Orion, MD
-
Columbus, Ohio, Forenede Stater, 43214
- Rekruttering
- Ohio Health Riverside
-
Ledende efterforsker:
- Joseph Campbell, MD
-
Kontakt:
- Regan Moran
- E-mail: Regan.Moran@ohiohealth.com
-
-
Oklahoma
-
Tulsa, Oklahoma, Forenede Stater, 74104
- Rekruttering
- Oklahoma Heart Institute
-
Ledende efterforsker:
- Julia Chen, MD
-
Kontakt:
- Tia Whitaker
- E-mail: Tia.Whitaker@hillcrest.com
-
-
Oregon
-
Portland, Oregon, Forenede Stater, 97239
- Rekruttering
- Portland VA Medical Center
-
Ledende efterforsker:
- Matthew Koopmann, MD
-
Kontakt:
- Rachel Nelson
- E-mail: Rachel.Nelson1@va.gov
-
-
Pennsylvania
-
Bethlehem, Pennsylvania, Forenede Stater, 18015
- Rekruttering
- St. Luke's University Health Network
-
Ledende efterforsker:
- Sharvil Sheth, MD
-
Kontakt:
- Jena Hagerty
- Telefonnummer: 484-658-4982
- E-mail: Jena.Hagerty@sluhn.org
-
Philadelphia, Pennsylvania, Forenede Stater, 19104
- Rekruttering
- Hospital of the University of Pennsylvania
-
Kontakt:
- Carolina Reyes
- Telefonnummer: 215-615-8036
- E-mail: carolina.reyes1@pennmedicine.upenn.edu
-
Ledende efterforsker:
- Grace Wang, MD
-
Philadelphia, Pennsylvania, Forenede Stater, 19107
- Rekruttering
- Jefferson Clinical Research Institute
-
Kontakt:
- Jona Shperdheja
- E-mail: Jona.Shperdheja@jefferson.edu
-
Ledende efterforsker:
- Michael Nooromid, MD
-
Pittsburgh, Pennsylvania, Forenede Stater, 15219
- Rekruttering
- University of Pittsburgh Medical Center
-
Kontakt:
- Judith Brimmeier
- E-mail: brimmeierja@upmc.edu
-
Ledende efterforsker:
- Raymond Eid, MD
-
-
South Carolina
-
Greenville, South Carolina, Forenede Stater, 29605
- Rekruttering
- Prisma Health
-
Ledende efterforsker:
- Mark P Androes, MD
-
Kontakt:
- Nikita Kasinger
- E-mail: Nikita.Kasinger@PrismaHealth.org
-
Kontakt:
- Maggie Salle
- E-mail: Margaret.Salle@PrismaHealth.org
-
-
South Dakota
-
Sioux Falls, South Dakota, Forenede Stater, 57108
- Rekruttering
- North Central Heart - A Division of Avera Heart Hospital
-
Ledende efterforsker:
- Michael Bacharach, MD
-
Kontakt:
- Patty Eisenbraun, RN
- Telefonnummer: 605-977-5336
- E-mail: peisenbraun@ncheart.com
-
-
Tennessee
-
Nashville, Tennessee, Forenede Stater, 37232
- Rekruttering
- Vanderbilt University Medical Center
-
Ledende efterforsker:
- John Curci, MD
-
Kontakt:
- Celia Nunez
- E-mail: celia.m.nunez@vumc.org
-
Kontakt:
- Jennifer Scott
- E-mail: jennifer.scott@vumc.org
-
Nashville, Tennessee, Forenede Stater, 37212
- Ikke rekrutterer endnu
- VA Tennessee Valley Healthcare System
-
Ledende efterforsker:
- John Curci, MD
-
Kontakt:
- Sohpia Miner
- E-mail: Sophia.Miner@va.gov
-
-
Texas
-
Houston, Texas, Forenede Stater, 77004
- Rekruttering
- Houston Healthcare
-
Ledende efterforsker:
- Kristofer Charlton-Ouw, MD
-
Kontakt:
- Swathi Potla
- E-mail: swathi.potla@hcahealthcare.com
-
Plano, Texas, Forenede Stater, 75093
- Rekruttering
- Baylor Scott & White Medical Center
-
Ledende efterforsker:
- William Shutze, MD
-
Kontakt:
- Saba Arianpour
- E-mail: Saba.Arianpour@BSWHealth.org
-
-
Utah
-
Salt Lake City, Utah, Forenede Stater, 84132
- Rekruttering
- University of Utah Hospital
-
Kontakt:
- Julie Hales
- E-mail: Julie.Hales@hsc.utah.edu
-
Ledende efterforsker:
- Cali Johnson, MD
-
-
Virginia
-
Fairfax, Virginia, Forenede Stater, 22031
- Rekruttering
- Inova Fairfax Medical Campus Inova Health Systems
-
Kontakt:
- Bhruga Shah
- E-mail: Bhruga.shah@inova.org
-
Ledende efterforsker:
- Kendal Endicott, MD
-
Norfolk, Virginia, Forenede Stater, 23507
- Rekruttering
- Sentara Health
-
Ledende efterforsker:
- David Dexter, MD
-
Kontakt:
- Angela Zahn
- E-mail: AXZAHN@sentara.com
-
-
Washington
-
Seattle, Washington, Forenede Stater, 98104
- Rekruttering
- University of Washington at Harborview Medical Center
-
Kontakt:
- Allison Larimore
- E-mail: alari@uw.edu
-
Ledende efterforsker:
- Benjamin Starnes, MD
-
-
Wisconsin
-
Green Bay, Wisconsin, Forenede Stater, 54301
- Rekruttering
- Bellin Memorial Hospital
-
Ledende efterforsker:
- Jason Ricci, MD
-
Kontakt:
- Katie Guilliams
- E-mail: Katherine.Guilliams@emplifyhealth.org
-
-
-
-
-
Auckland, New Zealand, 1023
- Rekruttering
- Auckland City Hospital
-
Kontakt:
- Cynthia Corne
- Telefonnummer: 21505 +64 9 307 4949
- E-mail: CorneC@adhb.govt.nz
-
Ledende efterforsker:
- Andrew Holden, A/Prof
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Males and females ≥21 to ≤85 years of age. Females must be of non-childbearing potential (menopause or sterilization).
- Subject understands the purpose of the trial, agrees to voluntarily participate in the trial, signs the informed consent and is willing to complete the follow-up according to the requirements of the protocol.
- Infrarenal atherosclerotic fusiform abdominal aortic aneurysm from 3.5 cm to 5.0 cm (male) and 3.5 cm to 4.5 cm (female).
- Infrarenal aortic neck ≥ 15 mm in length and ≤ 29 mm in diameter.
- Overall AAA treatment length (distal renal to distal inferior margin of the aneurysm) not to exceed 130 mm.
- Iliac and femoral artery access, vessel size and morphology allow endovascular access of 14F (or larger) introducer sheaths and catheters.
- Subject meets American Society of Anesthesiology (ASA) grade 1 through 3 criteria, inclusive.
- Subject has > three-year life expectancy.
- Subject is able and willing to comply with all required follow-up clinic visits including CT scans (pre-randomization, 6, 12, 18, 24 months and annually up to 5 years) and blood draws.
Exclusion Criteria:
- Subject has an acutely ruptured, leaking, dissecting or emergent aneurysm.
- Subject has a symptomatic infrarenal abdominal aortic aneurysm.
- Subject has a mycotic or infected aneurysm.
- Subject has current vascular injury due to trauma.
- Subject's aneurysm is thoracic, suprarenal or juxtarenal.
- Previous surgical or endovascular aneurysm repair for abdominal aortic aneurysm.
- Subject has anatomy of diffuse, ulcerated, or extensive (shaggy) thrombus in the neck of the AAA, that in the opinion of the vascular surgeon/investigator, could result in embolization of the thrombus.
- Subject has anatomy of calcification, and/or plaque within the ilio-femoral arteries or severe infrarenal neck angulation that may compromise or does not allow delivery of the Introducer Sheath or the delivery catheter of the Nectero EAST System.
- Subject has had a myocardial infarction within six (6) months prior to enrollment or elevated CK enzymes or troponin indicative of an evolving MI prior to procedure.
- Subject has current angina, unstable angina, or other active cardiac condition such as congestive heart failure III and IV, atrial arrhythmia, ventricular arrhythmia, or valvular disease, requiring intervention.
- Subject has undergone other major surgery within the 30 days prior to enrollment.
- Subjects with any transient ischemic attack (TIA) or ischemic stroke within 3 months.
- Known allergy to contrast material that cannot be adequately premedicated, delivery system materials (i.e., nylon, polyurethane) and/or pentagalloylglucose (PGG).
- Subject is morbidly obese or has other clinical conditions that severely inhibit X-ray visualization of the aorta.
- Subject has connective tissue/collagen disorder (e.g., Marfan syndrome, vascular Ehlers-Danlos Syndrome, Loeys-Dietz Syndrome, Eaton Syndrome, Bessel-Hagen disease, etc.).
- Known contraindication to undergoing angiography or receiving systemic anticoagulation during the procedure.
- Subject has active systemic infection.
- Subject is participating in another research trial that could interfere with the results of the trial (e.g., drug trial).
- Subject has other medical, social, or psychological problems that, in the opinion of the investigator, preclude them from participation in the trial and to undergo the procedures and evaluations pre- and post-treatment.
- Subject has dialysis dependent renal failure or baseline serum creatinine level >2.5mg/dL or eGFR < 45 mL/min/1.73m2.
- Subjects with aminotransferase (ALT and/or AST) which is ≥1.5x upper limit of normal (ULN) or TB that is our of normal range for the evaluating laboratory.
- Subjects that may not tolerate the lowering of their systolic blood pressure to approximately 100mmHg, should not be considered for this study or treated using the Nectero EAST System.
- Subjects that may not be able to tolerate transient occlusion of the aorta should not be considered for this study.
- Subjects with saccular AAA.
- Subjects with rapidly expanding AAA (previous diameter increases of ≥0.5 cm in 6-months or ≥1 cm in 1 year) as these should be evaluated for immediate repair.
- Subjects who are not suitable for the Nectero EAST System treatment, as determined by the investigator.
- Subjects with INR out of normal range for the evaluating laboratory for a subject not on anti-coagulant therapy; or INR >3 for a subject on anti-coagulant therapy.
- Subjects with active/acute or a history of unstable chronic liver disease or current liver disease including but not limited to liver transplant, known genetic disorders such as Gilbert syndrome or other liver diseases.
- Subjects with cirrhosis (e.g., known history or new clinical diagnosis by elastography with a fibrosis score of F3 or F4 and/or steatosis grade of S3).
- Subjects with uncontrolled alcohol use disorder or current alcohol use putting them at risk of liver disease: including consumption of above one standard drink per day for women and two standard drinks per day for men.
- Subjects with known right-sided heart failure or pathologically dilated inferior vena cava or hepatic veins indicative of congestive hepatopathy.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Treatment Arm
Participants assigned to the treatment arm will undergo an endovascular procedure using the Nectero EAST System to deliver the Stabilizer Infusion Solution directly inside the aneurysm. This is a one-time local delivery of the product. Following treatment, surveillance of their AAA will be conducted using CT scans at 6 months, 12 months, 18 months, 24 months, and annually for 5 years. Intervention: Drug: Stabilizer |
Treated subjects will undergo an endovascular procedure with the Nectero EAST system and receive the Stabilizer Infusion Solution (drug) within 30 days of the study eligibility by CT scan as a one-time local delivery of the drug. |
|
Ingen indgriben: Control Arm
Participants assigned to the control arm will undergo surveillance of their AAA using CT scans at 6 months, 12 months, 18 months, 24 months, and annually for 5 years. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Primary Endpoint
Tidsramme: 24 months
|
The primary endpoint is the composite of all AAA-related death, rupture and repair (open-surgical, EVAR, or clinically indicated for repair as adjudicated by a committee of clinical experts blinded to the assigned arm). |
24 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Growth
Tidsramme: 24 months
|
The growth over time in aneurysm diameter based on CT core laboratory readings. |
24 months
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Daniel Clair, MD, Vanderbilt University Medical Center
- Ledende efterforsker: Grace Wang, MD, University of Pennsylvania
Publikationer og nyttige links
Hjælpsomme links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- EAST002
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .